Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Keith Murphy currently holds 26,053 shares of Kintara Therapeutics, Inc. (KTRA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Keith Murphy has been a net seller of KTRA stock. They have purchased $552.4K and sold $5.0M worth of shares.
Keith Murphy's most recent insider trade was on Jan 27, 2026, when they sold 15,000 shares at $0.00 per share.
Keith Murphy serves as Executive at Kintara Therapeutics, Inc. (KTRA). They have executed 40 insider transactions totaling $5.6M over their tenure at the company.
Keith Murphy holds the position of Executive at Kintara Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 14 years and currently hold a stake valued at $0.
Keith Murphy has shown a selling trading pattern, with $552.4K in total purchases and $5.0M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Keith Murphy was on Jan 21, 2014, when they sold $1.1M worth of ONVO shares. This transaction involved 100,000 shares at $10.86 per share.
Keith Murphy currently owns 26,053 shares of Kintara Therapeutics, Inc. (KTRA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Keith Murphy's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Keith Murphy has 40 Form 4 filings on record as an insider at Kintara Therapeutics, Inc..
Set alerts for Keith Murphy and 40,000+ other insiders.